Are peptides legal in Arizona?
Peptide drugs are federally regulated. State pharmacy law governs compounding and dispensing, and the state board follows FDA 503A/503B bulk-substance rules. Arizona has a large wellness-clinic market; the board has issued guidance warning against dispensing FDA Category 2 peptides.
Compounding
Active compounding pharmacy sector
Primary citations
- A.R.S. Title 32 Ch. 18
What this means practically
Approved peptide drugs such as semaglutide, tirzepatide, and tesamorelin are obtainable in Arizona with a valid prescription from a licensed practitioner, dispensed by a licensed pharmacy. Telehealth access is permitted.
Peptides on the FDA's 503A Category 2 bulk list — including BPC-157, CJC-1295, ipamorelin, and thymosin alpha-1 — cannot lawfully be compounded by any pharmacy in Arizona, regardless of state rules, because the restriction is federal. Products sold online as "research chemicals" are not approved for human use.
This page tracks status only. It is not legal advice, and state boards update guidance frequently.